Form 4: Intra-Cellular Therapies Director Exercises Restricted Stock Units

Director Joel S. Marcus reports the exercise of restricted stock units and disposition of shares of Intra-Cellular Therapies, Inc.

Summary

• On June 23, 2024, Joel S. Marcus, a director of Intra-Cellular Therapies, Inc., exercised 1,567 restricted stock units, each representing a contingent right to receive one share of common stock.
• This transaction resulted in the disposition of 1,567 shares of common stock.
• Following the reported transaction, Marcus directly owns 41,229 shares of common stock and indirectly owns 10,000 shares through Alexandria Real Estate Equities, Inc.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing an insider transaction. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors and officers.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it involves the issuance and subsequent sale of a small number of shares.

Key Dates